Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ: MRVI · Real-Time Price · USD

6.23

-0.02 (-0.32%)

At close: Aug 7, 2026, 4:00 PM EDT

6.30

+0.07 (1.12%)

After-hours: Aug 7, 2026, 7:35 PM EDT

MRVI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	70.09	216.89	322.4	574.96	632.14	551.27
Cash & Short-Term Investments	70.09	216.89	322.4	574.96	632.14	551.27
Cash Growth	-74.03%	-32.73%	-43.93%	-9.04%	14.67%	133.41%
Accounts Receivable	31.14	25.5	38.52	54.61	138.62	117.51
Other Receivables	-	-	-	-	8.19	-
Total Trade Receivables	31.14	25.5	38.52	54.61	146.81	117.51
Inventory	41.23	40.5	50.08	51.4	43.15	51.56
Other Current Assets	13.2	13.37	18.15	18.95	25.8	19.7
Total Current Assets	155.66	296.25	429.15	699.91	847.9	740.04
Net Property, Plant & Equipment	142.41	151.48	164.47	162.9	52.69	46.33
Other Intangible Assets	138.38	151.54	194.96	220.99	216.66	117.57
Goodwill	129.43	129.43	159.88	326.03	283.67	152.77
Other Long-Term Assets	37.87	41.88	59.79	77.62	881.39	861.57
Total Assets	603.75	770.58	1,008	1,487	2,282	1,918

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.13	2.91	11.96	10.73	5.99	8.15
Accrued Expenses	30.17	36.57	39.57	60.24	53.37	34.57
Current Portion of Long-Term Debt	1.13	5.44	5.44	5.44	5.44	6
Current Portion of Leases	-	-	-	0.63	-	-
Unearned Revenue	-	-	-	3.36	3.09	10.21
Other Current Liabilities	-	-	-	7.07	42.25	34.84
Total Current Liabilities	38.42	44.92	56.97	87.47	110.14	93.78
Long-Term Debt	145.98	286.33	290.49	518.71	522	524.59
Long-Term Leases	29.59	30.14	31.11	31.9	-	-
Other Long-Term Liabilities	34.17	36.48	52.47	59.49	744.93	754.55
Total Long-Term Liabilities	209.74	352.95	374.06	610.1	1,267	1,279
Total Liabilities	248.16	397.87	431.04	697.57	1,377	1,373

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	2.6	2.56	2.53	2.51	2.55	2.55
Additional Paid-in Capital	207.6	199.18	181.87	128.5	137.9	128.39
Accumulated Other Comprehensive Income	0.46	0.52	-	-	-	-
Retained Earnings	-6.03	10.12	140.89	285.74	404.77	184.56
Total Common Shareholders' Equity	204.62	212.38	325.29	416.75	545.22	315.5
Minority Interest	150.97	160.33	251.92	373.13	360.03	229.86
Shareholders' Equity	355.59	372.71	577.21	789.88	905.24	545.36
Total Liabilities & Equity	603.75	770.58	1,008	1,487	2,282	1,918

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	176.7	321.91	327.04	556.68	527.44	530.59
Net Cash (Debt)	-106.61	-105.02	-4.64	18.29	104.7	20.68
Net Cash Growth	-	-	-	-82.54%	406.27%	-
Net Cash Per Share	-0.73	-0.73	-0.03	0.14	0.41	0.08
Book Value	204.62	212.38	325.29	416.75	545.22	315.5
Book Value Per Share	1.40	1.47	2.36	3.16	2.14	1.22
Tangible Book Value	-63.18	-68.59	-29.54	-130.26	44.89	45.16
Tangible Book Value Per Share	-0.43	-0.48	-0.21	-0.99	0.18	0.18

SEC Filings: 10-K · 10-Q